{
  "_id": "c2f4ab8b24ca66057ebc6de05acff293a45ded1905d353d1252acca1b09fd426",
  "feed": "market-watch",
  "title": "U.S. stocks edge higher, testing all time highs in final session before Christmas",
  "text": "<p>FDA adds Merck antiviral to COVID-19 tool kit for high-risk adults above 18 amid flurry of positive news on boosters</p><p>The U.S. Food and Drug Administration authorized Merck's COVID-19 antiviral for adults who have tested positive for the virus and are at high risk of disease progression early Thursday, granting it a more limited use than the rival one from Pfizer that was authorized on Wednesday. See full story.</p><p>U.S. consumer sentiment showing gradual improvement, UMich survey shows</p><p>The University of Michigan's gauge of consumer sentiment rose slightly to a final December reading of 70.6 from the initial reading of 70.4, staying above November's final level of 67.4. See full story.</p><p>I'll have $5 million for retirement when I sell my dental practice next year â€” but my wife and kids don't want me to retire</p><p>Have a question about your own retirement savings? Email us at HelpMeRetire@marketwatch.com See full story.</p><p>These wild market forecasts have a 50% chance of coming true in 2022, says hedge-fund investor</p><p>Our call of the day veers into what-if territory, with some rather outrageous (or maybe not) market forecasts gathered by hedge-fund manager Doug Kass. See full story.</p><p>MARKETWATCH PERSONAL FINANCE</p><p>The winter season isn't as cold as it was roughly 50 years ago, especially in the U.S. Northeast and for Great Lakes cities. See full story.</p>",
  "published": "2021-12-23T12:00:09.000Z",
  "tags": [
    {
      "id": "US58933Y1055",
      "name": "Merck & Co., Inc.",
      "offsets": [
        {
          "start": 166,
          "end": 171
        },
        {
          "start": 9,
          "end": 14
        }
      ],
      "nexusId": "10042334"
    }
  ]
}